Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Examples of dupixent biosimilars?

See the DrugPatentWatch profile for dupixent

Are there any Dupixent (dupilumab) biosimilars approved yet?

Dupixent (dupilumab) biosimilars are not listed here because the provided information set does not include approval status or product names.

What would “Dupixent biosimilar” examples usually include?

When people look for “examples of Dupixent biosimilars,” they typically mean approved biosimilar brands (or likely candidate names under review) that target dupilumab’s indication(s), such as:
- Atopic dermatitis
- Asthma (with type 2 inflammation)
- Chronic rhinosinusitis with nasal polyps
- Eosinophilic esophagitis

If you tell me the country, I can name specific products

Biosimilar availability depends heavily on where you are (U.S., EU, UK, Canada, etc.). If you share your country (or regulator—FDA vs EMA), I can list the real, currently approved Dupixent biosimilar examples for that market.

Want branded vs nonproprietary examples?

Also tell me if you want:
- Brand names (what patients see), or
- Nonproprietary names/INN + manufacturer (what research and prescriptions use)

Sources

None provided.



Other Questions About Dupixent :

when does dupixent patent expire biosimilar dupixent dupixent цена dupixent pricing when will dupixent become generic Dupixent biosimilar 2026? Dupixent biosimilar market 2026?